Cargando…
Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
PURPOSE: To evaluate clinical outcomes according to radiation dose in patients with limited-stage small-cell lung cancer (LS-SCLC) treated with concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2006 to December 2015, 38 patients with LS-SCLC were treated with CCRT with etoposi...
Autores principales: | Park, Junhee, Kang, Min Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903357/ https://www.ncbi.nlm.nih.gov/pubmed/29621871 http://dx.doi.org/10.3857/roj.2017.00311 |
Ejemplares similares
-
Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
por: Kang, Ki Mun, et al.
Publicado: (2012) -
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
por: Abacioglu, Ufuk, et al.
Publicado: (2005) -
Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
por: Kim, Byoung Hyuck, et al.
Publicado: (2023) -
Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
por: Ha, In-Bong, et al.
Publicado: (2013) -
Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
por: Conibear, John
Publicado: (2020)